Recent Finacing
Recent Raise
Elicio Therapeutics is a clinical-stage biotech developing Amphiphile (AMP) lymph‑node–targeted vaccines and immunotherapies— including ELI‑002 KRAS vaccine and multivalent AMP candidates for shared neoantigens.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Elicio Therapeutics.
